NibaLabs
NibaLabs is a highly specialized analytical laboratory supporting the cell and gene therapy (CGT) industry through advanced multiplex dPCR assay development and a broad range of GMP-compliant analytical services.
With the launch of NibaPlex® – the world's first all-in-one, ready-to-use multiplex dPCR assay for genome integrity quantification – NibaLabs has become a pivotal partner in CGT analytics.
We provide end-to-end analytical support from product development to commercial manufacturing, including site transfers, scale-up, process optimization, and batch-to-batch consistency.
Our analytical solutions ensure robust genome integrity monitoring, regulatory-compliant release specifications, and actionable insights that result in high-quality, safe, and efficacious CGT products.
